ALPS Advisors’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,076
| Closed | -$122K | – | 915 |
|
|
2018
Q3 | $122K | Buy |
2,076
+373
| +22% | +$21.9K | ﹤0.01% | 936 |
|
|
2018
Q2 | $90K | Buy |
1,703
+129
| +8% | +$6.82K | ﹤0.01% | 918 |
|
|
2018
Q1 | $443K | Buy |
1,574
+274
| +21% | +$77.1K | ﹤0.01% | 743 |
|
|
2017
Q4 | $306K | Buy |
1,300
+144
| +12% | +$33.9K | ﹤0.01% | 734 |
|
|
2017
Q3 | $328K | Buy |
1,156
+101
| +10% | +$28.7K | ﹤0.01% | 720 |
|
|
2017
Q2 | $297K | Buy |
1,055
+47
| +5% | +$13.2K | ﹤0.01% | 720 |
|
|
2017
Q1 | $336K | Sell |
1,008
-117
| -10% | -$39K | ﹤0.01% | 677 |
|
|
2016
Q4 | $372K | Buy |
+1,125
| New | +$372K | ﹤0.01% | 637 |
|
|
2016
Q2 | – | Sell |
-968
| Closed | -$171K | – | 633 |
|
|
2016
Q1 | $171K | Sell |
968
-166
| -15% | -$29.3K | ﹤0.01% | 607 |
|
|
2015
Q4 | $283K | Buy |
+1,134
| New | +$283K | ﹤0.01% | 654 |
|